GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Alibaba Health Information Technology 241.HK · HKD

Health Care · HKEX · 🇭🇰 Hong Kong

Compare

3.05

-1.61%

Close of 9 Nov 2026, in HKD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CNY, from our data supplier.

FY2025

Revenue

CN¥30.60bn

FY2016FY2025

Net income

CN¥1.43bn

FY2016FY2025

Free cash flow

CN¥1.38bn

FY2016FY2025

Shareholders' equity

CN¥16.31bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueCN¥30.60bnCN¥27.03bnCN¥26.76bnCN¥20.58bnCN¥15.52bnCN¥9.60bnCN¥5.10bnCN¥2.44bnCN¥475.1mCN¥56.6m
Research and developmentCN¥720.1mCN¥705.4mCN¥677.8mCN¥728.8mCN¥423.6mCN¥252.8mCN¥219.0mCN¥126.2mCN¥108.6m—
Operating incomeCN¥1.60bnCN¥725.3mCN¥31.0m−CN¥998.6mCN¥50.1m−CN¥27.8m−CN¥95.0m−CN¥134.4m−CN¥202.1m−CN¥216.0m
Net incomeCN¥1.43bnCN¥883.5mCN¥535.7m−CN¥265.6mCN¥348.6m−CN¥6.6m−CN¥81.9m−CN¥107.0m−CN¥207.6m−CN¥191.6m
Diluted earnings per share0.090.060.04-0.020.03-0.00-0.01-0.01-0.03-0.02

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsCN¥21.18bnCN¥19.71bnCN¥20.75bnCN¥19.20bnCN¥17.74bnCN¥7.87bnCN¥5.98bnCN¥3.11bnCN¥1.68bnCN¥1.35bn
Cash and short-term investmentsCN¥8.10bnCN¥9.55bnCN¥10.92bnCN¥10.55bnCN¥11.64bnCN¥3.00bnCN¥2.02bnCN¥1.40bnCN¥580.2mCN¥1.02bn
Total liabilitiesCN¥4.87bnCN¥5.16bnCN¥5.57bnCN¥5.10bnCN¥3.44bnCN¥2.60bnCN¥3.19bnCN¥530.7mCN¥501.9mCN¥126.8m
DebtCN¥35.5mCN¥82.2mCN¥77.8mCN¥135.4mCN¥37.7mCN¥69.8mCN¥1.70bn—CN¥200.0m—
Shareholders' equityCN¥16.31bnCN¥14.54bnCN¥15.17bnCN¥14.10bnCN¥14.30bnCN¥5.27bnCN¥2.79bnCN¥2.58bnCN¥1.18bnCN¥1.22bn
Shares outstanding16,136m14,091m13,542m13,483m13,327m11,931m11,055m9,188m8,179m8,173m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsCN¥1.40bnCN¥1.08bnCN¥255.7mCN¥424.4mCN¥1.01bnCN¥583.6mCN¥396.4m−CN¥70.3m−CN¥225.6m−CN¥117.2m
Capital spending−CN¥18.9m−CN¥22.8m−CN¥5.9m−CN¥15.1m−CN¥17.6m−CN¥13.5m−CN¥6.1m−CN¥5.7m−CN¥2.1m−CN¥8.7m
Free cash flowCN¥1.38bnCN¥1.06bnCN¥249.8mCN¥409.2mCN¥991.9mCN¥570.1mCN¥390.3m−CN¥76.0m−CN¥227.8m−CN¥125.9m

Latest quarters

By quarter end

Sept 2025Mar 2025Sept 2024Mar 2024Sept 2023Jun 2023Mar 2023Dec 2022
RevenueCN¥16.70bnCN¥16.32bnCN¥14.27bnCN¥14.07bnCN¥12.96bnCN¥6.48bnCN¥15.26bnCN¥7.63bn
Operating incomeCN¥1.18bnCN¥539.8mCN¥804.8mCN¥418.3mCN¥314.7mCN¥128.8mCN¥43.0mCN¥16.1m
Net incomeCN¥1.27bnCN¥663.5mCN¥769.0mCN¥437.6mCN¥445.9mCN¥222.6mCN¥373.5mCN¥186.1m
Diluted earnings per share0.080.040.050.030.030.020.030.01
Total assetsCN¥23.26bnCN¥21.18bnCN¥20.27bnCN¥19.71bnCN¥21.44bnCN¥21.44bnCN¥20.75bnCN¥20.75bn
Cash and short-term investmentsCN¥9.39bnCN¥8.10bnCN¥7.73bnCN¥9.55bnCN¥12.11bnCN¥12.11bnCN¥10.92bnCN¥10.92bn
DebtCN¥50.4mCN¥24.9mCN¥40.6mCN¥48.0mCN¥49.3mCN¥49.3mCN¥40.4mCN¥40.4m
Shareholders' equityCN¥17.57bnCN¥16.31bnCN¥15.28bnCN¥14.54bnCN¥16.09bnCN¥16.06bnCN¥15.17bnCN¥15.15bn

Growth per year

Compound annual rate

3 years5 years10 years
Revenue14.1%26.1%100.1%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin4.0%1.3%1.1%0.4%
Net margin4.0%2.5%2.3%1.6%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings49.045.692.1-290.1216.4-35331.4-1043.1-468.6-133.7-142.9
Price to sales2.31.51.83.74.924.316.820.558.4483.9

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 21 Jan 1998.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.